Myriad Genetics (MYGN) Change in Taxes (2010 - 2026)

Myriad Genetics has disclosed Change in Taxes across 17 years of filings, most recently posting -$10.0 million for Q1 2026.

• In Q1 2026, Change in Taxes fell 376.19% year-over-year to -$10.0 million; the TTM figure through Mar 2026 stood at -$12.3 million (down 207.5% YoY), while the FY2025 annual figure was -$4.4 million, down 780.0% from the prior year.
• Change in Taxes declined to -$10.0 million in Q1 2026, from -$1.8 million in the prior quarter.
• Over the last five years, Change in Taxes for MYGN reached as high as $1.4 million in Q1 2024 and fell as low as -$10.0 million in Q1 2026.
• The 5-year median for Change in Taxes is -$500000.0 (2023), against an average of -$1.2 million.
• Annual changes were most pronounced in 2022 — Change in Taxes soared 100.44% — and 2026, when it plunged 376.19%.
• A 5-year view of Change in Taxes shows it stood at -$200000.0 in 2022, then tumbled by 150.0% to -$500000.0 in 2023, then decreased by 20.0% to -$600000.0 in 2024, then tumbled by 200.0% to -$1.8 million in 2025, then plunged by 455.56% to -$10.0 million in 2026.
• According to Business Quant data, Change in Taxes over the past three periods registered -$10.0 million, -$1.8 million, and -$500000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.